Pneumococcal 21-valent Conjugate Vaccine Side Effects
Applies to pneumococcal 21-valent conjugate vaccine: intramuscular suspension.
Important warnings
This medicine can cause some serious health issues
You should not receive this vaccine if you ever had a severe allergic reaction to a pneumococcal or diphtheria toxoid vaccine.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Keep track of all side effects you have. If you ever need another pneumococcal 21-valent conjugate vaccine, you will need to tell the vaccination provider if the previous shot caused any side effects.
Becoming infected with pneumococcal disease is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is low.
Common side effects may include:
-
pain, swelling, or redness where a shot was given;
-
fever; or
-
feeling tired.
Call your doctor if your these side effects do not improve after 3 days or if you have any unusual symptoms after the vaccine.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For healthcare professionals
Applies to pneumococcal 21-valent conjugate vaccine: intramuscular suspension.
General adverse events
The most commonly reported side effects included injection site pain, fatigue, and headache.[Ref]
Local
- Very common (10% or more): Injection site pain (up to 73.3%), injection site erythema (up to 15.5%), injection site swelling (up to 14%)
- Frequency not reported: Injection site cellulitis[Ref]
In a clinical trial (n=56), injection site cellulitis occurred in 1 patient on Day 6 following vaccination and required hospitalization.[Ref]
Musculoskeletal
Nervous system
- Very common (10% or more): Headache (up to 29.5%)[Ref]
Other
- Very common (10% or more): Fatigue (up to 40.5%)
- Common (1% to 10%): Pyrexia[Ref]
Respiratory
- Frequency not reported: Bronchospasm[Ref]
In a clinical trial (n=56), bronchospasm occurred in 1 patient within 30 minutes of vaccination and required medical intervention.[Ref]
References
1. (2024) "Product Information. Capvaxive PF Prefilled Syringe (cvx 327) (pneumococcal 21-valent conjugate vaccine (cvx 327))." Merck Sharp & Dohme LLC
More about pneumococcal 21-valent conjugate vaccine
- Check interactions
- Compare alternatives
- Reviews (2)
- Dosage information
- During pregnancy
- Drug class: bacterial vaccines
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Pneumococcal 21-valent conjugate vaccine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.